Pluri (PLUR) News Today $4.82 +0.42 (+9.55%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Pluri congratulates Mesoblast, CEO on FDA approval of MSC-based therapyDecember 20 at 4:39 AM | markets.businessinsider.comPluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host DiseaseDecember 19 at 8:00 AM | globenewswire.comPluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025December 10, 2024 | markets.businessinsider.comPluri Inc.'s PluriCDMO™ Nominated for CDMO of the Year Award at Advanced Therapies Awards 2025December 9, 2024 | quiverquant.comPluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat ConcernsNovember 25, 2024 | markets.businessinsider.comBrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial ManufacturingNovember 11, 2024 | prnewswire.comPluri collaborates with Bar-Ilan University to advance cancer immunotherapyOctober 28, 2024 | markets.businessinsider.comPluri Flat on Funding From Innovation AuthorityOctober 28, 2024 | baystreet.caPluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation AuthorityOctober 28, 2024 | tmcnet.comPluri Inc. regains compliance with Nasdaq listing rulesOctober 3, 2024 | investing.comPlurilock Appoints David Kris, Former Head of the Department of Justice’s National Security Division, to Industry Advisory CouncilSeptember 16, 2024 | msn.comOgun PDP caretaker chair hails violent-free ward congressAugust 31, 2024 | msn.comPlurilock Security Inc. Reports Second Quarter Fiscal 2024 Financial ResultsAugust 31, 2024 | msn.comRAMSAY SANTE: Provisional annual results at the end of June 2024August 30, 2024 | finanznachrichten.deCell Therapy Manufacturing Market Size Projected to Reach USD 17.3 Billion by 2034, at 13.90% CAGR: Prophecy Market InsightsAugust 30, 2024 | uk.finance.yahoo.comPlurilock Engages Clear Street to Review U.S. Strategic OptionsAugust 26, 2024 | msn.comA look ahead to MK Dons' home game against Carlisle UnitedAugust 24, 2024 | msn.comMental Health Matters: Seven Tips To Better Support LGBTQ+ ProfessionalsAugust 20, 2024 | forbes.comPluri-Investissements C (0P000025S3.F)August 15, 2024 | uk.finance.yahoo.comHalf of LGBTQ+ professionals have experienced depression & few feel they can be “authentic” at workJuly 20, 2024 | msn.comPluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product CandidatesJuly 18, 2024 | globenewswire.comPluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability ChallengesJune 18, 2024 | globenewswire.comU.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome ContractJune 6, 2024 | globenewswire.comNovel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial ScaleMay 20, 2024 | globenewswire.comPluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)May 12, 2024 | finance.yahoo.comUnleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer TreatmentMay 2, 2024 | globenewswire.comPackers will face the Eagles in Brazil's first NFL game everApril 11, 2024 | msn.comPluri Inc. announces breakthrough in immune cell therapy productionApril 10, 2024 | uk.investing.comPluri stock jumps 9% on US patent for immune cell productionApril 8, 2024 | msn.comBreakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New MethodApril 8, 2024 | globenewswire.comPLUR Stock Earnings: Pluri Reported Results for Q4 2023April 3, 2024 | investorplace.comReAlta signs deal with NIAID to develop drug for radiation poisoningMarch 29, 2024 | msn.comTrading was temporarily halted for "PLUR" at 07:03 PM with a stated reason of "News pending."March 29, 2024 | marketbeat.comPluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesMarch 28, 2024 | finance.yahoo.comPluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesMarch 28, 2024 | globenewswire.comPluri Inc. Announces 1-for-8 Reverse Share SplitMarch 27, 2024 | globenewswire.comPluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportMarch 21, 2024 | globenewswire.comEngage with Pluri's Talent: Exciting Conference Appearances AheadMarch 19, 2024 | globenewswire.comPluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingMarch 14, 2024 | globenewswire.comPluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationMarch 11, 2024 | globenewswire.comPluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardMarch 6, 2024 | globenewswire.comPluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsFebruary 28, 2024 | finance.yahoo.comPluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsFebruary 28, 2024 | globenewswire.comStelmine Secures Minuapan for Further ExplorationFebruary 22, 2024 | msn.comGiant Strides Of Isa Kutepa’s Waltersmith PetromanFebruary 21, 2024 | msn.comStelmine increases significantly the length of the gold-bearing corridor at MercatorFebruary 21, 2024 | finance.yahoo.comMeatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food TechnologyFebruary 15, 2024 | finance.yahoo.comPluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)February 14, 2024 | finance.yahoo.comIsrael’s cell-based coffee: Sustainable solution to brewing industry challenges?January 25, 2024 | msn.comStep into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisJanuary 23, 2024 | finance.yahoo.com Get Pluri News Delivered to You Automatically Sign up to receive the latest news and ratings for PLUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Icon: “You must get on the right side of this thing” (Ad)I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years. This market shakeup is going to be much more intense. PLUR Media Mentions By Week PLUR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLUR News Sentiment▼0.480.59▲Average Medical News Sentiment PLUR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLUR Articles This Week▼21▲PLUR Articles Average Week Get Pluri News Delivered to You Automatically Sign up to receive the latest news and ratings for PLUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Journey Medical News Today Skye Bioscience News Today Context Therapeutics News Today Alto Neuroscience News Today Immunic News Today Avalo Therapeutics News Today Pyxis Oncology News Today Century Therapeutics News Today Tonix Pharmaceuticals News Today Tiziana Life Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLUR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pluri Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pluri With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
